α- and β-Adrenergic receptors differentially modulate the emission of spontaneous and amphetamine-induced 50-kHz ultrasonic vocalizations in adult rats

Neuropsychopharmacology

Volumn 37, Issue 3, 2012, Pages 808-821

  Wright, Jennifer M ^a   Dobosiewicz, May R S ^a   Clarke, Paul B S ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b Concordia University ^*  (Canada)

Author keywords

amphetamine; cocaine; noradrenaline; rat; trills; ultrasonic vocalizations

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR; AMPHETAMINE; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR INTRINSIC ACTIVITY; ULTRASOUND; VOCALIZATION;

ADRENERGIC AGONISTS; ADRENERGIC ANTAGONISTS; AMPHETAMINE; ANIMALS; CENTRAL NERVOUS SYSTEM STIMULANTS; MALE; RATS; RATS, LONG-EVANS; RECEPTORS, ADRENERGIC, ALPHA; RECEPTORS, ADRENERGIC, BETA; VOCALIZATION, ANIMAL;

EID: 84855908923     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2011.258     Document Type: Article

References (125)

1. Abi-Dargham A, Kegeles LS, Martinez D, Innis RB, Laruelle M (2003). Dopamine mediation of positive reinforcing effects of amphetamine in stimulant naive healthy volunteers: results from a large cohort. Eur Neuropsychopharmacol 13:459-468. (Pubitemid 37433966)
2. Ahrens AM, Ma ST, Maier EY, Duvauchelle CL, Schallert T (2009). Repeated intravenous amphetamine exposure: rapid and persistent sensitization of 50-kHz ultrasonic trill calls in rats. Behav Brain Res 197:205-209.
3. Alsene KM, Carasso BS, Connors EE, Bakshi VP (2006). Disruption of prepulse inhibition after stimulation of central but not peripheral alpha-1 adrenergic receptors. Neuropsychopharmacology 31:2150-2161. (Pubitemid 44413192)
4. Anden NE, Corrodi H, Fuxe K, Hokfelt B, Hokfelt T, Rydin C et al (1970). Evidence for a central noradrenaline receptor stimulation by clonidine. Life Sci 9:513-523.
5. Angel I, Le RM, Pimoule C, Graham D, Arbilla S (1995). [3H]cirazoline as a tool for the characterization of imidazoline sites. Ann N Y Acad Sci 763:112-124.
6. Arborelius L, Wallsten C, Ahlenius S, Svensson TH (1999). The 5-HT (1A) receptor antagonist robalzotan completely reverses citalopram-induced inhibition of serotonergic cell firing. Eur J Pharmacol 382:133-138. (Pubitemid 29488746)
7. Arnt J (1996). Inhibitory effects on the discriminative stimulus properties of D-amphetamine by classical and newer antipsychotics do not correlate with antipsychotic activity. Relation to effects on the reward system? Psychopharmacology (Berl) 124:117-125.
8. Asin KE, Wirtshafter D (1985). Clonidine produces a conditioned place preference in rats. Psychopharmacology (Berl) 85:383-385. (Pubitemid 15123118)
9. Baker JG (2005). The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors. Br J Pharmacol 144:317-322. (Pubitemid 40313677)
10. Balle T, Perregaard J, Ramirez MT, Larsen AK, Soby KK, Liljefors T et al (2003). Synthesis and structure-affinity relationship investigations of 5-heteroaryl-substituted analogues of the antipsychotic sertindole. A new class of highly selective alpha (1) adrenoceptor antagonists. J Med Chem 46:265-283. (Pubitemid 36078145)
11. Barker DJ, Root DH, Ma S, Jha S, Megehee L, Pawlak AP et al (2010). Dose-dependent differences in short ultrasonic vocalizations emitted by rats during cocaine self-administration. Psychopharmacology (Berl) 211:435-442.
12. Bennett DA, Lal H (1982). Discriminative stimuli produced by clonidine: an investigation of the possible relationship to adrenoceptor stimulation and hypotension. J Pharmacol Exp Ther 223:642-648. (Pubitemid 13170082)
13. Berridge KC, Robinson TE (1998). What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience? Brain Res Brain Res Rev 28:309-369. (Pubitemid 29012677)
14. Blumberg MS, Johnson ED, Middlemis-Brown JE (2005). Inhibition of ultrasonic vocalizations by beta-adrenoceptor agonists. Dev Psychobiol 47:66-76. (Pubitemid 40961307)
15. Bondi CO, Jett JD, Morilak DA (2010). Beneficial effects of desipramine on cognitive function of chronically stressed rats are mediated by alpha1-adrenergic receptors in medial prefrontal cortex. Prog Neuropsychopharmacol Biol Psychiatry 34:913-923.
16. Brauer LH, de Wit H (1995). Role of dopamine in d-amphetamineinduced euphoria in normal, healthy volunteers. Exp Clin Psychopharmacol 3:371-381.
17. Brauer LH, de Wit H (1996). Subjective responses to damphetamine alone and after pimozide pretreatment in normal, healthy volunteers. Biol Psychiatry 39:26-32. (Pubitemid 26024199)
18. Brauer LH, de Wit H (1997). High dose pimozide does not block amphetamine-induced euphoria in normal volunteers. Pharmacol Biochem Behav 56:265-272. (Pubitemid 27115914)
19. Browning JR, Browning DA, Maxwell AO, Dong Y, Jansen HT, Panksepp J et al (2011). Positive affective vocalizations during cocaine and sucrose self-administration: A model for spontaneous drug desire in rats. Neuropharmacology 61:268-275.
20. Brudzynski SM (2005). Principles of rat communication: quantitative parameters of ultrasonic calls in rats. Behav Genet 35:85-92. (Pubitemid 40228511)
21. Burgdorf J, Knutson B, Panksepp J, Ikemoto S (2001). Nucleus accumbens amphetamine microinjections unconditionally elicit 50-kHz ultrasonic vocalizations in rats. Behav Neurosci 115:940-944. (Pubitemid 32738340)
22. Burgdorf J, Kroes RA, Moskal JR, Pfaus JG, Brudzynski SM, Panksepp J (2008a). Ultrasonic vocalizations of rats (Rattus norvegicus) during mating, play, and aggression: behavioral concomitants, relationship to reward, and self-administration of playback. J Comp Psychol 122:357-367.
23. Burgdorf J, Moskal JR (2009). Frequency modulated 50kHz ultrasonic vocalizations reflect a positive emotional state in the rat: neural substrates and therapeutic implications. In: Brudzynski SM (ed). Handbook of Mammalian Vocalization. Academic Press: Oxford. pp 209-214.
24. Burgdorf J, Panksepp J (2006). The neurobiology of positive emotions. Neurosci Biobehav Rev 30:173-187. (Pubitemid 41821807)
25. Burgdorf J, Panksepp J, Brudzynski SM, Beinfeld MC, Cromwell HC, Kroes RA et al (2008b). The effects of selective breeding for differential rates of 50-kHz ultrasonic vocalizations on emotional behavior in rats. Dev Psychobiol 51:34-46.
26. Burgdorf J, Panksepp J, Moskal JR (2010). Frequency-modulated 50 kHz ultrasonic vocalizations: a tool for uncovering the molecular substrates of positive affect. Neurosci Biobehav Rev 9:1831-1836.
27. Burgdorf J, Wood PL, Kroes RA, Moskal JR, Panksepp J (2007). Neurobiology of 50-kHz ultrasonic vocalizations in rats: electrode mapping, lesion, and pharmacology studies. Behav Brain Res 182:274-283. (Pubitemid 47411465)
28. Carey RJ, DePalma G, Shanahan A, Damianopoulos EN, Muller CP, Huston JP (2008). Effects on spontaneous and cocaine-induced behavior of pharmacological inhibition of noradrenergic and serotonergic systems. Pharmacol Biochem Behav 89:54-63.
29. Cervo L, Rossi C, Samanin R (1993). Clonidine-induced place preference is mediated by alpha 2-adrenoceptors outside the locus coeruleus. Eur J Pharmacol 238:201-207. (Pubitemid 23214432)
30. Ciucci MR, Ahrens AM, Ma ST, Kane JR, Windham EB, Woodlee MT et al (2009). Reduction of dopamine synaptic activity: degradation of 50-kHz ultrasonic vocalization in rats. Behav Neurosci 123:328-336.
31. Ciucci MR, Ma ST, Fox C, Kane JR, Ramig LO, Schallert T (2007). Qualitative changes in ultrasonic vocalization in rats after unilateral dopamine depletion or haloperidol: a preliminary study. Behav Brain Res 182:284-289. (Pubitemid 47411464)
32. Clineschmidt BV, Flataker LM, Faison E, Holmes R (1979). An in vivo model for investigating alpha 1-and alpha 2-receptors in the CNS: studies with mianserin. Arch Int Pharmacodyn Ther 242:59-76. (Pubitemid 10132524)
33. Couch MW, Greer DM, Thonoor CM, Williams CM (1988). In vivo binding in rat brain and radiopharmaceutical preparation of radioiodinated HEAT, an alpha-1 adrenoceptor ligand. J Nucl Med 29:356-362. (Pubitemid 18086794)
34. Covington HEI, Miczek KA (2003). Vocalizations during withdrawal from opiates and cocaine: possible expressions of affective distress. Eur J Pharmacol 467:1-13. (Pubitemid 36423379)
35. Darracq L, Blanc G, Glowinski J, Tassin JP (1998). Importance of the noradrenaline-dopamine coupling in the locomotor activating effects of D-amphetamine. J Neurosci 18:2729-2739. (Pubitemid 28141818)
36. Davis WM, Smith SG (1977). Catecholaminergic mechanisms of reinforcement: direct assessment by drug-self-administration. Life Sci 20:483-492. (Pubitemid 8051882)
37. De Luca LAJ, Nunes de Souza RL, Yada MM, Meyer EW (1999). Sedation and need-free salt intake in rats treated with clonidine. Pharmacol Biochem Behav 62:585-589. (Pubitemid 29127161)
38. Dlugos A, Freitag C, Hohoff C, McDonald J, Cook EH, Deckert J et al (2007). Norepinephrine transporter gene variation modulates acute response to D-amphetamine. Biol Psychiatry 61:1296-1305. (Pubitemid 46726264)
39. Doxey JC, Lane AC, Roach AG, Virdee NK (1984). Comparison of the alpha-adrenoceptor antagonist profiles of idazoxan (RX 781094), yohimbine, rauwolscine and corynanthine. Naunyn Schmiedebergs Arch Pharmacol 325:136-144. (Pubitemid 14169919)
40. Drew GM, Gower AJ, Marriott AS (1979). Alpha 2-adrenoceptors mediate clonidine-induced sedation in the rat. Br J Pharmacol 67:133-141. (Pubitemid 10232249)
41. Drouin C, Blanc G, Villegier AS, Glowinski J, Tassin JP (2002). Critical role of alpha1-adrenergic receptors in acute and sensitized locomotor effects of D-amphetamine, cocaine, and GBR 12783: influence of preexposure conditions and pharmacological characteristics. Synapse 43:51-61. (Pubitemid 33115667)
42. Edwards L, Fishman D, Horowitz P, Bourbon N, Kester M, Ernsberger P (2001). The I1-imidazoline receptor in PC12 pheochromocytoma cells activates protein kinases C, extracellular signal-regulated kinase (ERK) and c-jun N-terminal kinase (JNK). J Neurochem 79:931-940. (Pubitemid 33117071)
43. Ettenberg A (2004). Opponent process properties of self-administered cocaine. Neurosci Biobehav Rev 27:721-728. (Pubitemid 38199604)
44. Fischman MW, Schuster CR, Resnekov L, Shick JF, Krasnegor NA, Fennell W et al (1976). Cardiovascular and subjective effects of intravenous cocaine administration in humans. Arch Gen Psychiatry 33:983-989.
45. Florin SM, Kuczenski R, Segal DS (1994). Regional extracellular norepinephrine responses to amphetamine and cocaine and effects of clonidine pretreatment. Brain Res 654:53-62. (Pubitemid 24259401)
46. Foltin RW, Fischman MW (1991). Assessment of abuse liability of stimulant drugs in humans: a methodological survey. Drug Alcohol Depend 28:3-48.
47. Forget B, Hamon M, Thiebot MH (2009). Involvement of alpha1-adrenoceptors in conditioned place preference supported by nicotine in rats. Psychopharmacology (Berl) 205:503-515.
48. Gawin FH (1986). Neuroleptic reduction of cocaine-induced paranoia but not euphoria? Psychopharmacology (Berl) 90:142-143. (Pubitemid 16075176)
49. Georges F, Caille S, Vouillac C, Le MC, Stinus L (2005). Role of imidazoline receptors in the anti-aversive properties of clonidine during opiate withdrawal in rats. Eur J Neurosci 22:1812-1816. (Pubitemid 41482971)
50. Grilly DM, Loveland A (2001). What is a 'low dose' of damphetamine for inducing behavioral effects in laboratory rats? Psychopharmacology (Berl) 153:155-169. (Pubitemid 32127883)
51. Gunne LM, Anggard E, Jonsson LE (1972). Clinical trials with amphetamine-blocking drugs. Psychiatr Neurol Neurochir 75:225-226.
52. Harris GC, Hedaya MA, Pan WJ, Kalivas P (1996). beta-adrenergic antagonism alters the behavioral and neurochemical responses to cocaine. Neuropsychopharmacology 14:195-204.
53. Hoffman DC, Donovan H (1995). Effects of typical, atypical, and novel antipsychotic drugs on amphetamine-induced place conditioning in rats. Drug Dev Res 36:193-198. (Pubitemid 26062136)
54. Holt A (2003). Imidazoline binding sites on receptors and enzymes: emerging targets for novel antidepressant drugs? J Psychiatry Neurosci 28:409-414. (Pubitemid 38091171)
55. Johansson L, Sohn D, Thorberg SO, Jackson DM, Kelder D, Larsson LG et al (1997). The pharmacological characterization of a novel selective 5-hydroxytryptamine1A receptor antagonist, NAD-299. J Pharmacol Exp Ther 283:216-225. (Pubitemid 27438965)
56. Jonsson L-E (1972). Pharmacological blockade of amphetamine effects in amphetamine dependent subjects. Eur J Clin Pharmacol 4:206-211.
57. Jonsson LE, Anggard E, Gunne LM (1971). Blockade of intravenous amphetamine euphoria in man. Clin Pharmacol Ther 12:889-896.
58. Jonsson LE, Gunne LM, Anggard E (1969). Effects of alphamethyltyrosine in amphetamine-dependent subjects. Eur J Clin Pharmacol 2:27-29.
59. Kaltwasser MT (1990). Acoustic signaling in the black rat (Rattus rattus). J Comp Psychol 104:227-232.
60. Knutson B, Burgdorf J, Panksepp J (2002). Ultrasonic vocalizations as indices of affective states in rats. Psychol Bull 128:961-977.
61. Leyton M, aan het Rot M, Booij L, Baker GB, Young SN, Benkelfat C (2007). Mood-elevating effects of d-amphetamine and incentive salience: the effect of acute dopamine precursor depletion. J Psychiatry Neurosci 32:129-136. (Pubitemid 46597959)
62. Leyton M, Casey KF, Delaney JS, Kolivakis T, Benkelfat C (2005). Cocaine craving, euphoria, and self-administration: a preliminary study of the effect of catecholamine precursor depletion. Behav Neurosci 119:1619-1627. (Pubitemid 43145732)
63. Litvin Y, Blanchard DC, Blanchard RJ (2007). Rat 22 kHz ultrasonic vocalizations as alarm cries. Behav Brain Res 182:166-172. (Pubitemid 47101902)
64. Lott DC, Kim SJ, Cook Jr EH, de WH (2005). Dopamine transporter gene associated with diminished subjective response to amphetamine. Neuropsychopharmacology 30:602-609. (Pubitemid 40271162)
65. Ma ST, Maier EY, Ahrens AM, Schallert T, Duvauchelle CL (2010). Repeated intravenous cocaine experience: development and escalation of pre-drug anticipatory 50-kHz ultrasonic vocalizations in rats. Behav Brain Res 212:109-114.
66. Maier EY, Ahrens AM, Ma ST, Schallert T, Duvauchelle CL (2010). Cocaine deprivation effect: cue abstinence over weekends boosts anticipatory 50-kHz ultrasonic vocalizations in rats. Behav Brain Res 214:75-79.
67. McIntosh TK, Barfield RJ (1984). Brain monoaminergic control of male reproductive behavior. III. Norepinephrine and the post-ejaculatory refractory period. Behav Brain Res 12:275-281. (Pubitemid 14094268)
68. McKittrick CR, Abercrombie ED (2007). Catecholamine mapping within nucleus accumbens: differences in basal and amphetamine-stimulated efflux of norepinephrine and dopamine in shell and core. J Neurochem 100:1247-1256.
69. Meyer PJ, Ma ST, Robinson TE (2011). A cocaine cue is more preferred and evokes more frequency-modulated 50-kHz ultrasonic vocalizations in rats prone to attribute incentive salience to a food cue. Psychopharmacology (Berl) (in press).
70. Miach PJ, Dausse JP, Cardot A, Meyer P (1980). 3H-Prazosin binds specifically to 'alpha 1'-adrenoceptors in rat brain. Naunyn Schmiedebergs Arch Pharmacol 312:23-26. (Pubitemid 10120375)
71. Micheletti G, Warter JM, Marescaux C, Depaulis A, Tranchant C, Rumbach L et al (1987). Effects of drugs affecting noradrenergic neurotransmission in rats with spontaneous petit mal-like seizures. Eur J Pharmacol 135:397-402. (Pubitemid 17057566)
72. Middlemiss DN, Neill J, Tricklebank MD (1985). Subtypes of the 5-HT receptor involved in hypothermia and forepaw treading induced by 8-OH-DPAT. Br J Pharmacol 85:251P.
73. Middlemiss DN, Tricklebank MD (1992). Centrally active 5-HT receptor agonists and antagonists. Neurosci Biobehav Rev 16:75-82.
74. Molinari EJ, North PC, Dubocovich ML (1996). 2-[125I]iodo-5- methoxycarbonylamino-N-acetyltryptamine: a selective radioligand for the characterization of melatonin ML2 binding sites. Eur J Pharmacol 301:159-168.
75. Mu P, Fuchs T, Saal DB, Sorg BA, Dong Y, Panksepp J (2009). Repeated cocaine exposure induces sensitization of ultrasonic vocalization in rats. Neurosci Lett 453:31-35.
76. Nomikos GG, Spyraki C (1988). Cocaine-induced place conditioning: importance of route of administration and other procedural variables. Psychopharmacology (Berl) 94:119-125. (Pubitemid 18009075)
77. Nurnberger JI, Simmons-Alling S, Kessler L, Jimerson S, Schreiber J, Hollander E et al (1984). Separate mechanisms for behavioral, cardiovascular, and hormonal responses to dextroamphetamine in man. Psychopharmacology (Berl) 84:200-204. (Pubitemid 14006573)
78. Pan WH, Sung JC, Fuh SM (1996). Locally application of amphetamine into the ventral tegmental area enhances dopamine release in the nucleus accumbens and the medial prefrontal cortex through noradrenergic neurotransmission. J Pharmacol Exp Ther 278:725-731. (Pubitemid 27167039)
79. Panksepp J, Burgdorf J (2000). 50-kHz chirping (laughter?) in response to conditioned and unconditioned tickle-induced reward in rats: effects of social housing and genetic variables. Behav Brain Res 115:25-38.
80. Pickering DS, Niles LP (1990). Pharmacological characterization of melatonin binding sites in Syrian hamster hypothalamus. Eur J Pharmacol 175:71-77. (Pubitemid 20027650)
81. Pintor J, Martin L, Pelaez T, Hoyle CH, Peral A (2001). Involvement of melatonin MT (3) receptors in the regulation of intraocular pressure in rabbits. Eur J Pharmacol 416:251-254. (Pubitemid 32274253)
82. Portfors CV (2007). Types and functions of ultrasonic vocalizations in laboratory rats and mice. J Am Assoc Lab Anim Sci 46:28-34. (Pubitemid 46953141)
83. Roberts DC, Morgan D, Liu Y (2007). How to make a rat addicted to cocaine. Prog Neuropsychopharmacol Biol Psychiatry 31:1614-1624. (Pubitemid 47625707)
84. Ross SB, Thorberg S, Jerning E, Mohell N, Stenfors C, Wallsten C et al (1999). Robalzotan (NAD-299), a novel selective 5-HT1A receptor antagonist. CNS Drug Rev 5:213-232. (Pubitemid 29519650)
85. Rothman RB, Baumann MH, Dersch CM, Romero DV, Rice KC, Carroll FI et al (2001). Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin. Synapse 39:32-41.
86. Sacchetti G, Bernini M, Gobbi M, Parini S, Pirona L, Mennini T et al (2001). Chronic treatment with desipramine facilitates its effect on extracellular noradrenaline in the rat hippocampus: studies on the role of presynaptic alpha2-adrenoceptors. Naunyn Schmiedebergs Arch Pharmacol 363:66-72. (Pubitemid 32060088)
87. Sales GD, Pye D (1974). Ultrasonic Communication by Animals. Chapman and Hall: London.
88. Sanger DJ (1989). Discriminative stimulus effects of the alpha 2-adrenoceptor antagonist idazoxan. Psychopharmacology (Berl) 99:117-121. (Pubitemid 19201726)
89. Sara SJ, Dyon-Laurent C, Herve A (1995). Novelty seeking behavior in the rat is dependent upon the integrity of the noradrenergic system. Brain Res Cogn Brain Res 2:181-187.
90. Schechter MD (1991). Discriminative stimulus effect of phenylephrine. Arch Int Pharmacodyn Ther 309:20-31.
91. Schiff AA, Saxey A (1984). Autoradiography of nadolol and propranolol in the rat. Xenobiotica 14:687-691. (Pubitemid 15200398)
92. Schoffelmeer AN, Mulder AH (1984). Presynaptic opiate receptorand alpha 2-adrenoceptor-mediated inhibition of noradrenaline release in the rat brain: role of hyperpolarization? Eur J Pharmacol 105:129-135. (Pubitemid 14006342)
93. Schwarting RK, Jegan N, Wohr M (2007). Situational factors, conditions and individual variables which can determine ultrasonic vocalizations in male adult Wistar rats. Behav Brain Res 182:208-222. (Pubitemid 47101905)
94. Sebban C, Zhang XQ, Tesolin-Decros B, Millan MJ, Spedding M (1999). Changes in EEG spectral power in the prefrontal cortex of conscious rats elicited by drugs interacting with dopaminergic and noradrenergic transmission. Br J Pharmacol 128:1045-1054. (Pubitemid 29512038)
95. Segal DS, Kuczenski R (1997). An escalating dose 'binge' model of amphetamine psychosis: behavioral and neurochemical characteristics. J Neurosci 17:2551-2566. (Pubitemid 27137421)
96. Selken J, Nichols DE (2007). Alpha1-adrenergic receptors mediate the locomotor response to systemic administration of (+/-)-3, 4- methylenedioxymethamphetamine (MDMA) in rats. Pharmacol Biochem Behav 86:622-630. (Pubitemid 46829314)
97. Sellings LH, McQuade LE, Clarke PB (2006). Evidence for multiple sites within rat ventral striatum mediating cocaine-conditioned place preference and locomotor activation. J Pharmacol Exp Ther 317:1178-1187. (Pubitemid 43764123)
98. Sharp T, Bramwell SR, Hjorth S, Grahame-Smith DG (1989). Pharmacological characterization of 8-OH-DPAT-induced inhibition of rat hippocampal 5-HT release in vivo as measured by microdialysis. Br J Pharmacol 98:989-997. (Pubitemid 19269825)
99. Simola N, Ma ST, Schallert T (2009). Influence of acute caffeine on 50-kHz ultrasonic vocalizations in male adult rats and relevance to caffeine-mediated psychopharmacological effects. Int J Neuropsychopharmacol 13:123-132.
100. Simon P, Chermat R, Fosset MT, Boissier JR (1972). [Adrenergic blocking agents and amphetamine or apomorphine induced stereotyped behavior in rats]. Psychopharmacologia 23:357-364.
101. Skolnick P, Daly JW, Segal DS (1978). Neurochemical and behavioral effects of clonidine and related imidazolines: interaction with alpha-adrenoceptors. Eur J Pharmacol 47:451-455.
102. Snoddy AM, Tessel RE (1983). Nisoxetine and amphetamine share discriminative stimulus properties in mice. Pharmacol Biochem Behav 19:205-210. (Pubitemid 13011184)
103. Snoddy AM, Tessel RE (1985). Prazosin: effect on psychomotorstimulant cues and locomotor activity in mice. Eur J Pharmacol 116:221-228. (Pubitemid 16191811)
104. Sofuoglu M, Poling J, Hill K, Kosten T (2009). Atomoxetine attenuates dextroamphetamine effects in humans. Am J Drug Alcohol Abuse 35:412-416.
105. Stolerman I (1992). Drugs of abuse: behavioural principles, methods and terms. Trends Pharmacol Sci 13:170-176.
106. Swerdlow NR, Bongiovanni MJ, Tochen L, Shoemaker JM (2006). Separable noradrenergic and dopaminergic regulation of prepulse inhibition in rats: implications for predictive validity and Tourette syndrome. Psychopharmacology (Berl) 186:246-254. (Pubitemid 43727342)
107. Takahashi N, Kashino M, Hironaka N (2010). Structure of rat ultrasonic vocalizations and its relevance to behavior. PLoS ONE 5:e14115.
108. Tanda G, Bassareo V, Di CG (1996). Mianserin markedly and selectively increases extracellular dopamine in the prefrontal cortex as compared to the nucleus accumbens of the rat. Psychopharmacology (Berl) 123:127-130. (Pubitemid 26041911)
109. Thompson B, Leonard KC, Brudzynski SM (2006). Amphetamineinduced 50kHz calls from rat nucleus accumbens: a quantitative mapping study and acoustic analysis. Behav Brain Res 168:64-73. (Pubitemid 43152054)
110. Tornatzky W, Miczek KA (1994). Behavioral and autonomic responses to intermittent social stress: differential protection by clonidine and metoprolol. Psychopharmacology (Berl) 116:346-356. (Pubitemid 24345287)
111. Vanderschuren LJ, Beemster P, Schoffelmeer AN (2003). On the role of noradrenaline in psychostimulant-induced psychomotor activity and sensitization. Psychopharmacology (Berl) 169:176-185. (Pubitemid 37129969)
112. Virtanen R, Savola JM, Saano V (1989). Highly selective and specific antagonism of central and peripheral alpha 2-adrenoceptors by atipamezole. Arch Int Pharmacodyn Ther 297:190-204. (Pubitemid 19066359)
113. Vivian JA, Miczek KA (1993). Morphine attenuates ultrasonic vocalization during agonistic encounters in adult male rats. Psychopharmacology (Berl) 111:367-375. (Pubitemid 23165268)
114. Weinshenker D, Schroeder JP (2007). There and back again: a tale of norepinephrine and drug addiction. Neuropsychopharmacology 32:1433-1451. (Pubitemid 46920149)
115. West WB, Van Groll BJ, Appel JB (1995). Stimulus effects of damphetamine II: DA, NE, and 5-HT mechanisms. Pharmacol Biochem Behav 51:69-76.
116. White NR, Cagiano R, Moises AU, Barfield RJ (1990). Changes in mating vocalizations over the ejaculatory series in rats (Rattus norvegicus). J Comp Psychol 104:255-262.
117. Williams SN, Undieh AS (2010). Brain-derived neurotrophic factor signaling modulates cocaine induction of reward-associated ultrasonic vocalization in rats. J Pharmacol Exp Ther 332:463-468.
118. Wintink AJ, Brudzynski SM (2001). The related roles of dopamine and glutamate in the initiation of 50-kHz ultrasonic calls in adult rats. Pharmacol Biochem Behav 70:317-323. (Pubitemid 33049943)
119. Wohr M, Houx B, Schwarting RK, Spruijt B (2008). Effects of experience and context on 50-kHz vocalizations in rats. Physiol Behav 93:766-776. (Pubitemid 351381074)
120. Wohr M, Kehl M, Borta A, Schanzer A, Schwarting RK, Hoglinger GU (2009). New insights into the relationship of neurogenesis and affect: tickling induces hippocampal cell proliferation in rats emitting appetitive 50-kHz ultrasonic vocalizations. Neuroscience 163:1024-1030.
121. Wohr M, Schwarting RKW (2009). Activation of limbic system structures by replay of ultrasonic vocalization in rats. In: Brudzynski SM (ed). Handbook of Mammalian Vocalization: An Integratice Neuroscience Approach pp 113-124, Academic Press: Oxford.
122. Wortley KE, Heal DJ, Stanford SC (1999). Modulation of sibutramine-induced increases in extracellular noradrenaline concentration in rat frontal cortex and hypothalamus by alpha2-adrenoceptors. Br J Pharmacol 128:659-666. (Pubitemid 29504757)
123. Wright JM, Gourdon JC, Clarke PB (2010). Identification of multiple call categories within the rich repertoire of adult rat 50-kHz ultrasonic vocalizations: effects of amphetamine and social context. Psychopharmacology (Berl) 211:1-13.
124. Yokel RA, Wise RA (1976). Attenuation of intravenous amphetamine reinforcement by central dopamine blockade in rats. Psychopharmacology (Berl) 48:311-318.
125. Zarrindast MR, Bahreini T, Adl M (2002). Effect of imipramine on the expression and acquisition of morphine-induced conditioned place preference in mice. Pharmacol Biochem Behav 73:941-949. (Pubitemid 35246243)